Alum (KAl(SO4)2 ꢁ 12H2O)
1255
(1991) Phosphorus, Sulfur Silicon Relat Elem 57: 11; e)
Milcent R, Barbier G (1983) J Heterocycl Chem 20: 77;
f) Singh SP, Batra H, Sharma PK (1997) J Chem Res (S)
12: 468; g) Lutun S, Hasiak B, Couturier D (1999) Synth
Commun 29: 111; h) Isobe T, Ishikawa T (1999) J Org
Chem 64: 6989; i) Tandon VK, Chhor RB (1999) Synth
Commun 31: 1727; j) Natero R, Koltun DO, Ablocki JA
(2004) Synth Commun 34: 2523; k) Sharma GVM,
Begum A, Krishna PR (2004) Synth Commun 34:
2387; l) Yang YH, Shi M (2005) Tetrahedron Lett
46: 6285; m) Dabiri M, Salehi P, Baghbanzadeh M,
Bahramnejad M (2006) Tetrahedron Lett 47: 6983
[7] a) Hamad ASS, Hashem HI (2002) J Heterocycl Chem
39: 1325; b) Kerr VN, Ott DG, Hayes FN (1960) J Am
Chem Soc 82: 186
[8] Borg S, Vollinga RC, Labarre M, Payza K, Terenius L,
Luthman K (1999) J Med Chem 42: 4331
[9] Carlsen PHJ, Jorgensen KB (1994) J Heterocycl Chem
31: 805
[10] Short FW, Long LN (1969) J Heterocycl Chem 6: 7
[11] Reddy CK, Reddy PSN, Ratnam CV (1983) Synthesis
842
[12] Spiros L, Allen MP, Segelstein BE (2000) Synth Com-
mun 30: 437
2-(3-Nitrophenyl)-1,3,4-oxadiazole (3h, C8H5N3O3)
Mp 125–126ꢂC; IR (KBr): ꢀꢀ¼ 1611 (C¼N), 1524, 1462,
1059 cmꢄ1; 1H NMR (CDCl3, 300 MHz): ꢁ ¼ 7.75–8.59 (m,
4H, Ar–H), 8.93 (s, CH) ppm; 13C NMR (CDCl3, 75 MHz):
ꢁ ¼ 122.06, 125.19, 126.43, 130.57, 132.68, 148.66,
174.81 ppm; MS: m=z (%) ¼ 191 (Mþ, 100), 150 (48), 117
(25), 90 (78).
2-Methyl-5(3-nitrophenyl)-1,3,4-oxadiazole (3i, C9H7N3O3)
Mp 156–158ꢂC; IR (KBr): ꢀꢀ¼ 1586, 1561, 1467, 1062 cmꢄ1
;
1H NMR (CDCl3, 300 MHz): ꢁ ¼ 2.68 (s, CH3), 7.71–8.84
(4H, m, Ar–H) ppm; 13C NMR (CDCl3, 75MHz): ꢁ ¼
111.69, 121.63, 125.57, 126.01, 130.42, 132.28, 148.61,
163.61, 164.54 ppm; MS: m=z (%) ¼ 205 (Mþ, 100), 150
(48), 104 (32), 76 (30), 15 (45).
2-Phenyl-1,3,4-oxadiazole (3l, C8H6N2O)
Mp 150–152ꢂC; IR (KBr): ꢀꢀ¼ 1598, 1574, 1481, 1070, 712,
691 cmꢄ1; 1H NMR (DMSO-d6, 300 MHz): ꢁ ¼ 7.45–7.83 (m,
5H, Ar–H), 8.10 (s, CH) ppm; 13C NMR (CDCl3, 75 MHz):
ꢁ ¼ 127.91, 128.93, 129.05, 132.34, 160.39, 165.69 ppm; MS:
m=z (%) ¼ 147 (M þ 1, 25), 146 (Mþ, 22), 105 (100), 77 (100).
2-Ethyl-5-phenyl-1,3,4-oxadiazole (3m, C10H10N2O)
[13] Rigo B, Cauliez P (1986) Synth Commun 16: 1665
[14] a) Brain CT, Paul JM, Loong Y, Oakley PJ (1999)
Tetrahedron Lett 40: 3275; b) Brain CT, Brunton SA
(2001) Synlett 382; c) Brown B, Clemens I, Neesom JK
(2000) Synlett 131
Mp 104–105ꢂC; IR (KBr): ꢀꢀ¼ 1573, 1533, 1483, 1057,
795, 689cmꢄ1; 1H NMR (CDCl3, 300 MHz): ꢁ ¼ 1.12 (t, J ¼
6.75Hz, CH3), 2.31 (q, J ¼ 6.75 Hz, CH2), 7.34–7.784 (m, 5H,
Ar–H) ppm; 13C NMR (CDCl3, 75MHz): ꢁ ¼ 9.61, 27.33,
127.57, 128.65, 131.31, 132.38, 165.38, 172.64 ppm; MS:
m=z (%) ¼ 174 (Mþ, 45), 136 (23), 105 (100), 77 (73), 51 (23).
[15] a) Ainsworth C (1955) J Am Chem Soc 77: 1148; b)
Leiby RW (1984) J Heterocycl Chem 21: 1825; c) Shafiee
A, Naimi E, Mansobi P, Foroumadi A, Shekari M (1995)
J Heterocycl Chem 32: 1235; d) Khajavi MS, Sadat
Hosseini SS, Sefidkon F (1997) Iran J Chem Chem
Eng 16: 68; e) Dabiri M, Salehi P, Baghbanzadeh M,
Bahramnejad M (2007) Synth Commun 37: 1201
[16] Tanaka K, Toda F (2000) Chem Rev 100: 1025
[17] a) Dabiri M, Salehi P, Mohammadi AA, Baghbanzadeh
M (2005) Synth Commun 35: 279; b) Salehi P, Dabiri M,
Baghbanzadeh M, Bahramnejad M (2006) Synth Com-
mun 36: 2287; c) Dabiri M, Salehi P, Mohammadi AA,
Baghbanzadeh M, Kozehgiry G (2004) J Chem Res (S)
570; d) Salehi P, Dabiri M, Zolfigol MA, Bodaghi Fard
MA (2003) Tetrahdron Lett 44: 2889; e) Salehi P, Dabiri
M, Zolfigol MA, Baghbanzadeh M (2005) Synlett 1155;
f) Salehi P, Dabiri M, Khosropour AR, Roozbehniya P
(2006) J Iran Chem Soc 3: 98; g) Salehi P, Dabiri M,
Zolfigol MA, Baghbanzadeh M (2005) Tetrahedron Lett
46: 7051; h) Salehi P, Dabiri M, Zolfigol MA, Otokesh S,
Baghbanzadeh M (2006) Tetrahedron Lett 47: 2557; i)
Baghbanzadeh M, Salehi P, Dabiri M, Kozehgary GH
(2006) Synthesis 344; j) Dabiri M, Salehi P, Zolfigol
MA, Baghbanzadeh M (2007) Heterocycles 71: 677
[18] a) Dabiri M, Salehi P, Baghbanzadeh M, Kiani S,
Acknowledgement
Financial support by the Research Council of Shahid Beheshti
University and CCE is gratefully acknowledged.
References
[1] a) Ates O, Kocabalkanli A, Sanis GO, Ekini AC, Vidin A
(1997) Drug Res 47: 1134; b) Dabhi TP, Shah VH, Parikh
AR (1992) Indian J Pharm Sci 54: 98; c) Hui XP, Zhang
LM, Zhang ZY, Wang Q, Wang F (1999) Indian J Chem
Sect B Org Chem Incl Med Chem 38: 1066
[2] a) Holla BS, Gonsalves R, Shenoy S (2000) Eur J Med
Chem 35: 267; b) Cesur N, Birteksoz S, Otuk G (2002)
Acta Pharm Turcica 44: 23; c) Laddi UV, Desai SR,
Bennur RS, Bennur SC (2002) Indian J Heterocycl
Chem 11: 319
[3] Tyagi M, Kumar A (2002) Oriental J Chem 18: 125
[4] Zheng X, Li Z, Wang Y Chen W, Huang Q, Liu C,
Song G (2003) J Fluorine Chem 123: 163
[5] Zou XJ, Lai LH, Jin GY, Zhang ZX (2002) J Agric Food
Chem 50: 3757
[6] a) Rigo B, Fassuer D, Cauliez P, Couturier D (1989)
Synth Commun 19: 2321; b) Rigo B, Cauliez P, Fasseur
D, Couturier D (1988) Synth Commun 18: 1247; c)
Singh SP, Naithani R, Batra H, Prakash O, Sharma D
(1998) Indian J Heterocycl Chem 8: 103; d) Froeyen P
Vakilzadeh Y (2007) Monatsh Chem 138: (in
press); b) Azizian J, Mohammadi AA, Karimi AR,
Mohammadizadeh MR (2005) J Org Chem 70: 350
[19] Rostamizadeh S, Ghasem Housaini SA (2004) Tetrahe-
dron Lett 45: 8753